Intravenous blood thinner cangrelor improves heart recovery after cardiogenic shock

This announcement highlights that cangrelor, a potent intravenous blood thinner, leads to better heart function recovery in heart attack patients who develop cardiogenic shock compared to oral antiplatelet therapy. The finding is significant as cardiogenic shock is the most serious complication following a heart attack.

Originally published by gnews